Eppdata is uniquely positioned to support the lifecycle of clinical studies with information technology development and domain specific medical expertise.
Hamburg
Joined January 2025
- Tweets7
- Following2
- Followers10
- Likes4
Congratulations! We keep up with the ratings. Promised. @CheesemakerMD @FishingNeurons @StrokeEso79453
We鈥檝e just enrolled the 100th patient in the #TECNO trial 馃捒馃帀
A huge thank you to all sites, teams, and patients for making this progress possible 馃檹
Congratulations: Great engineering and impressive results. TICI double read with full end-to-end traceability. Proud to be part of your journey! @Fie0815 @RaulNogueiraMD
Preliminary results from the MARRS pivotal IDE trial were presented at @SNISinfo, highlighting Millipede88 performance in acute ischemic stroke:
馃敼 77% First Pass Effect for M1 occlusions
馃敼 99% Delivery success
馃敼 Promising safety profile
bit.ly/3Gu2mFT
@Wayne_Perfuze
ERASER is the first mechanical thrombectomy study with a primary endpoint based on predictive analytics enabling intraindividual virtual comparisons.
This innovative study design paves the way for faster, more reliable evaluations in clinical trials.
#Stroke #NeuroIntervention
MMA embolization reduces treatment failures in chronic subdural hematoma by over 50%.
Eppdata provided core lab services for the STEM trial.
Read more at the NEJM: bit.ly/3DH8Ak0
Interested in advancing your research?
馃摡 Contact us today!
#MedicalResearch
Trustworthy data is the cornerstone of any successful clinical trial.
At Eppdata we're committed to :
Secure Data Handling
Standardized Imaging Protocols
Unbiased Analysis
Ready to elevate your research?
馃摡 Contact us today!
#dataIntegrity #corelab #MedicalResearch
Eppdata provided core lab services for the TENSION trial, proving that patients with large infarcts benefit from endovascular thrombectomy.
Check out recent The Lancet publication:
lnkd.in/gj4SZKYQ
馃摡 Contact us to collaborate on your next neurovascular trial!
#corelab
